About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

PIL Raises The Issue Of Spurious Drugs

by Medindia Content Team on June 15, 2006 at 7:12 PM
Font : A-A+

PIL Raises The Issue Of Spurious Drugs

A PIL in the Bombay High Court today raised the issue of spurious drugs, demanding that state government be directed to take steps to curb the trade of such drugs.

The High Court has directed the state government to file a reply in this regard by July 12.

Advertisement

The PIL was filed by Lakhpat Raj Mehta, who lost his son due to administration of spurious injection of the drug `Imipenam' at KEM hospital in Pune in March 2002.

Mehta had taken his two sons, Aman and Alpesh to the hospital following a minor mishap. He purchased the injection from KEM hospital's drug store. But the shot produced a lethal reaction in Aman, who died on April 6.

The injection was later found to be spurious, following which criminal case was initiated aginst the KEM authorities, which is still pending in the High Court.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 
Recommended Reading
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use